Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFα-activated B16F10 cells to fibronectin and endothelial cells

Chemotherapy

Volumn 56, Issue 1, 2010, Pages 82-88

  Jain, Meenakashi ^a   Ratheesh, Aparna ^a   Gude, Rajiv P ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

1 Integrin; 12(S) HETE; Cell adhesion; Integrin avidity; Pentoxifylline; Protein kinase C; TNF

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; HYDROXYICOSATETRAENOIC ACID; PENTOXIFYLLINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL LINE, TUMOR; ENDOTHELIAL CELLS; FIBRONECTINS; INTEGRINS; MELANOMA, EXPERIMENTAL; MICE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950522580     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000298823     Document Type: Article

References (28)

1. Clezardin P: Recent insights into the role of integrins in cancer metastasis. Cell Mol Life Sci 1998; 54: 541-548.
2. Belloni PN, Tressler RJ: Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells. Cancer Metastasis Rev 1990; 8: 353-389.
3. Bicknell R: Heterogeneity of the endothelial cell. Behring Inst Mitt 1993; 92: 1-7.
4. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA: Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res 1990; 50: 6757-6764.
5. Danen EH, Ten Berge PJ, Van Muijen GN, Van't Hof-Grootenboer AE, Brocker EB, Ruiter DJ: Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology 1994; 24: 249-256.
6. Moretti S, Martini L, Berti E, Pinzi C, Giannotti B: Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res 1993; 3: 235-239.
7. Ratheesh A, Ingle A, Gude RP: Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components. Cancer Biol Ther 2007; 6: 1743-1752.
8. Kawashima A, Kawahara E, Tokuda R, Nakanishi I: Tumour necrosis factor-alpha provokes upregulation of 2,1 and 5,1 integrins, and cell migration in OST osteosarcoma cells. Cell Biol Int 2001; 25: 319-329.
9. Pidgeon GP, Tang K, Cai YL, Piasentin E, Honn KV: Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing v 3 and v 5 integrin expression. Cancer Res 2003; 63: 4258-4267.
10. Hofmann MA, Gabriel V, Milling A, Kiecker F, Sterry W, Trefzer U: High-dose platinum combination therapy in pretreated patients with disseminated melanoma. Chemotherapy 2007; 53: 422-428.
11. Ott PA, Chang JL, Oratz R, Jones A, Farrell K, Muggia F, Pavlick AC: Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma. Chemotherapy 2009; 55: 221-227.
12. Gastpar H, Ambrus JL, Ambrus CM, Spavento P, Weber FJ, Thurber LE: Study of platelet aggregation in vivo. III. Effect of pentoxifylline. J Med 1977; 8: 191-197. (Pubitemid 8158430)
13. Gude RP, Ingle AD, Rao SG: Inhibition of lung homing of B16F10 by pentoxifylline, a microfilament depolymerizing agent. Cancer Lett 1996; 106: 171-176.
14. Ng T, Shima D, Squire A, Bastiaens PI, Gschmeissner S, Humphries MJ, Parker PJ: PKC regulates 1 integrin-dependent cell motility through association and control of integrin traffic. EMBO J 1999; 18: 3909-3923.
15. Dua P, Ingle A, Gude RP: Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma. Int J Cancer 2007; 121: 1600-1608.
16. Liaw L, Schwartz SM: Comparison of gene expression in bovine aortic endothelium in vivo versus in vitro. Differences in growth regulatory molecules. Arterioscler Thromb 1993; 13: 985-993.
17. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL: Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol 1997; 157: 2329-2333.
18. Gehlsen KR, Davis GE, Sriramarao P: Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 1992; 10: 111-120.
19. Kovach NL, Lindgren CG, Fefer A, Thompson JA, Yednock T, Harlan JM: Pentoxifylline inhibits integrin-mediated adherence of interleukin-2-activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells. Blood 1994; 84: 2234-2242.
20. Tang DG, Diglio CA, Honn KV: 12(S)- HETE-induced microvascular endothelial cell retraction results from PKC-dependent rearrangement of cytoskeletal elements and alpha V beta 3 integrins. Prostaglandins 1993; 45: 249-267.
21. Tang DG, Honn KV: Role of protein kinase C and phosphatases in 12(S)-HETE-induced tumor cell cytoskeletal reorganization. Adv Exp Med Biol 1997; 400A:349-361.
22. Timar J, Tang D, Bazaz R, Haddad MM, Kimler VA, Taylor JD, Honn KV: PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells. Cell Motil Cytoskeleton 1993; 26: 49-65.
23. Javaid K, Rahman A, Anwar KN, Frey RS, Minshall RD, Malik AB: Tumor necrosis factor- alpha induces early-onset endothelial adhesivity by protein kinase C-dependent activation of intercellular adhesion molecule- 1. Circ Res 2003; 92: 1089-1097.
24. Sheski FD, Natarajan V, Pottratz ST: Tumor necrosis factor-alpha stimulates attachment of small cell lung carcinoma to endothelial cells. J Lab Clin Med 1999; 133: 265-273.
25. Mukhopadhyay R, Theriault RL, Price JE: Increased levels of - 6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin Exp Metastasis 1999; 17: 325-332.
26. Schadendorf D, Gawlik C, Haney U, Ostmeier H, Suter L, Czarnetzki BM: Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol 1993; 170: 429-434.
27. Adachi M, Taki T, Higashiyama M, Kohno N, Inufusa H, Miyake M: Significance of integrin - 5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res 2000; 6: 96-101.
28. Lorger M, Krueger JS, O'Neal M, Staflin K, Felding-Habermann B: Activation of tumor cell integrin -v -3 controls angiogenesis and metastatic growth in the brain. Proc Natl Acad Sci USA 2009; 106: 10666-10671.